rs72558028

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_199037.5(SCN1B):​c.769G>A​(p.Gly257Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00217 in 1,549,766 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. The gene SCN1B is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.0016 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0022 ( 3 hom. )

Consequence

SCN1B
NM_199037.5 missense

Scores

1
13

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:14

Conservation

PhyloP100: -0.295

Publications

15 publications found
Variant links:
Genes affected
SCN1B (HGNC:10586): (sodium voltage-gated channel beta subunit 1) Voltage-gated sodium channels are heteromeric proteins that function in the generation and propagation of action potentials in muscle and neuronal cells. They are composed of one alpha and two beta subunits, where the alpha subunit provides channel activity and the beta-1 subunit modulates the kinetics of channel inactivation. This gene encodes a sodium channel beta-1 subunit. Mutations in this gene result in generalized epilepsy with febrile seizures plus, Brugada syndrome 5, and defects in cardiac conduction. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Oct 2009]
HPN-AS1 (HGNC:47041): (HPN antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004362136).
BP6
Variant 19-35034060-G-A is Benign according to our data. Variant chr19-35034060-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 190850.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0016 (243/152268) while in subpopulation NFE AF = 0.00231 (157/68006). AF 95% confidence interval is 0.00201. There are 1 homozygotes in GnomAd4. There are 119 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 3 AD,AR,Unknown gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_199037.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN1B
NM_001037.5
MANE Select
c.448+321G>A
intron
N/ANP_001028.1Q07699-1
SCN1B
NM_199037.5
c.769G>Ap.Gly257Arg
missense
Exon 3 of 3NP_950238.1Q07699-2
SCN1B
NM_001321605.2
c.349+321G>A
intron
N/ANP_001308534.1A0A1W2PR05

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCN1B
ENST00000415950.5
TSL:1
c.769G>Ap.Gly257Arg
missense
Exon 3 of 3ENSP00000396915.2Q07699-2
SCN1B
ENST00000262631.11
TSL:1 MANE Select
c.448+321G>A
intron
N/AENSP00000262631.3Q07699-1
SCN1B
ENST00000638536.1
TSL:1
c.448+321G>A
intron
N/AENSP00000492022.1Q07699-1

Frequencies

GnomAD3 genomes
AF:
0.00160
AC:
243
AN:
152150
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000845
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00157
Gnomad ASJ
AF:
0.00403
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000848
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00231
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.00143
AC:
221
AN:
154558
AF XY:
0.00157
show subpopulations
Gnomad AFR exome
AF:
0.000627
Gnomad AMR exome
AF:
0.000567
Gnomad ASJ exome
AF:
0.00305
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000851
Gnomad NFE exome
AF:
0.00251
Gnomad OTH exome
AF:
0.00138
GnomAD4 exome
AF:
0.00223
AC:
3114
AN:
1397498
Hom.:
3
Cov.:
31
AF XY:
0.00222
AC XY:
1532
AN XY:
689372
show subpopulations
African (AFR)
AF:
0.000824
AC:
26
AN:
31560
American (AMR)
AF:
0.000560
AC:
20
AN:
35700
Ashkenazi Jewish (ASJ)
AF:
0.00362
AC:
91
AN:
25168
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35732
South Asian (SAS)
AF:
0.000240
AC:
19
AN:
79200
European-Finnish (FIN)
AF:
0.000730
AC:
36
AN:
49282
Middle Eastern (MID)
AF:
0.00123
AC:
7
AN:
5694
European-Non Finnish (NFE)
AF:
0.00259
AC:
2795
AN:
1077234
Other (OTH)
AF:
0.00207
AC:
120
AN:
57928
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
167
335
502
670
837
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
100
200
300
400
500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00160
AC:
243
AN:
152268
Hom.:
1
Cov.:
32
AF XY:
0.00160
AC XY:
119
AN XY:
74436
show subpopulations
African (AFR)
AF:
0.000842
AC:
35
AN:
41566
American (AMR)
AF:
0.00157
AC:
24
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00403
AC:
14
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4808
European-Finnish (FIN)
AF:
0.000848
AC:
9
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00231
AC:
157
AN:
68006
Other (OTH)
AF:
0.00189
AC:
4
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
13
25
38
50
63
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00232
Hom.:
1
Bravo
AF:
0.00172
TwinsUK
AF:
0.00216
AC:
8
ALSPAC
AF:
0.00208
AC:
8
ESP6500AA
AF:
0.000883
AC:
2
ESP6500EA
AF:
0.00319
AC:
14
ExAC
AF:
0.00102
AC:
37
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not provided (6)
-
-
3
not specified (3)
-
-
2
Brugada syndrome 5 (2)
-
-
1
Cardiovascular phenotype (1)
-
-
1
Generalized epilepsy with febrile seizures plus, type 1;C2748541:Brugada syndrome 5;C3809311:Atrial fibrillation, familial, 13;C4479236:Developmental and epileptic encephalopathy, 52 (1)
-
-
1
SCN1B-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.089
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.40
CADD
Benign
0.96
DANN
Benign
0.22
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.0054
N
LIST_S2
Benign
0.33
T
MetaRNN
Benign
0.0044
T
MetaSVM
Benign
-0.67
T
PhyloP100
-0.29
PrimateAI
Benign
0.25
T
PROVEAN
Benign
0.040
N
REVEL
Benign
0.16
Sift
Pathogenic
0.0
D
Polyphen
0.0010
B
Vest4
0.71
MutPred
0.33
Gain of MoRF binding (P = 0.0025)
MVP
0.27
MPC
0.80
ClinPred
0.0026
T
GERP RS
-2.0
gMVP
0.11
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72558028; hg19: chr19-35524964; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.